Free Newsletter
Ratiopharm to surpass 2009 earnings goals
Free newsletter via e-mail
Tools
You all know that Germany's Ratiopharm is currently on the block, with a sale planned for early next year. What you might not know is that the company is set to beat its own goals for 2009 profits. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: